Stevanato Group SpA (STVN)
22.49
+0.95
(+4.41%)
USD |
NYSE |
Sep 16, 16:00
22.49
0.00 (0.00%)
After-Hours: 20:00
Stevanato Group Enterprise Value : 6.300B for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 6.300B |
| September 14, 2026 | 6.240B |
| September 11, 2026 | 6.125B |
| September 10, 2026 | 6.139B |
| September 09, 2026 | 5.945B |
| September 08, 2026 | 5.967B |
| September 04, 2026 | 6.018B |
| September 03, 2026 | 6.027B |
| September 02, 2026 | 6.079B |
| September 01, 2026 | 6.073B |
| August 31, 2026 | 6.270B |
| August 28, 2026 | 6.160B |
| August 27, 2026 | 6.507B |
| August 26, 2026 | 6.529B |
| August 25, 2026 | 6.617B |
| August 24, 2026 | 6.499B |
| August 21, 2026 | 6.589B |
| August 20, 2026 | 6.521B |
| August 19, 2026 | 6.346B |
| August 18, 2026 | 6.207B |
| August 17, 2026 | 6.223B |
| August 14, 2026 | 6.169B |
| August 13, 2026 | 6.294B |
| August 12, 2026 | 6.221B |
| August 11, 2026 | 6.166B |
| Date | Value |
|---|---|
| August 10, 2026 | 6.038B |
| August 07, 2026 | 5.953B |
| August 06, 2026 | 5.958B |
| August 05, 2026 | 5.906B |
| August 04, 2026 | 5.784B |
| August 03, 2026 | 6.040B |
| July 31, 2026 | 5.838B |
| July 30, 2026 | 5.934B |
| July 29, 2026 | 5.991B |
| July 28, 2026 | 5.920B |
| July 27, 2026 | 5.824B |
| July 24, 2026 | 5.792B |
| July 23, 2026 | 5.715B |
| July 22, 2026 | 5.707B |
| July 21, 2026 | 5.633B |
| July 20, 2026 | 5.647B |
| July 17, 2026 | 5.652B |
| July 16, 2026 | 5.906B |
| July 15, 2026 | 5.579B |
| July 14, 2026 | 5.830B |
| July 13, 2026 | 5.819B |
| July 10, 2026 | 5.767B |
| July 09, 2026 | 5.811B |
| July 08, 2026 | 5.693B |
| July 07, 2026 | 5.767B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 44.56B |
| Bio-Rad Laboratories, Inc. | 9.857B |
| Bruker Corp. | 10.15B |
| Danaher Corp. | 170.68B |
| Harvard Bioscience, Inc. | 74.12M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 26.69M |
| Revenue (Quarterly) | 351.14M |
| Total Expenses (Quarterly) | 324.45M |
| EPS Diluted (Quarterly) | 0.0978 |
| Gross Profit Margin (Quarterly) | 27.86% |
| Profit Margin (Quarterly) | 7.60% |
| Earnings Yield | 2.56% |
| Operating Earnings Yield | 3.87% |
| Normalized Earnings Yield | 2.633 |